Search

Your search keyword '"STENOTROPHOMONAS maltophilia"' showing total 7,167 results

Search Constraints

Start Over You searched for: Descriptor "STENOTROPHOMONAS maltophilia" Remove constraint Descriptor: "STENOTROPHOMONAS maltophilia"
7,167 results on '"STENOTROPHOMONAS maltophilia"'

Search Results

1. Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter study.

2. Stenotrophomonas maltophilia sepsis in preterm neonates.

3. Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period.

4. Colonisation by multidrug-resistant organisms in health workers in primary care: narrow spectrum oral antimicrobials are a risk factor.

5. Discovery of a new class of bacterial heme-containing C[dbnd]C cleaving oxygenases.

6. Structural diversity and clustering of bacterial flagellar outer domains.

7. Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?

8. Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study.

9. Symbiotic and Nonsymbiotic Bacteria Associated With the Entomo‐Pathogenic Nematode, Heterorhabditis spp (Rhabditida: Heterorhabditidae) From South India.

10. Removal of amoxicillin and co-amoxiclav by newly isolated Stenotrophomonasmaltophilia DF1.

11. Efficacy of two different microbial consortia on salinity tolerance in chickpea: an in-planta evaluation on biochemical, histochemical, and genomic aspects.

12. Protein-protein interaction network study of metallo-beta-lactamase-L1 present in Stenotrophomonas maltophilia and identification of potential drug targets.

13. A pan-genomic analysis based multi-epitope vaccine development by targeting Stenotrophomonas maltophilia using reverse vaccinology method: an in-silico approach.

14. From Glory to Decline: Uncovering Causes of Oak Decline in Iran.

15. Analysis of Stenotrophomonas maltophilia infections in lower respiratory tract samples at a university hospital: 5 year data.

16. Substrate preference, RNA binding and active site versatility of Stenotrophomonas maltophilia nuclease SmNuc1, explained by a structural study.

17. Case report: Personalized triple phage-antibiotic combination therapy to rescue necrotizing fasciitis caused by Panton-Valentine leukocidin-producing MRSA in a 12-year-old boy.

18. Prevalence and Molecular Epidemiology of Intestinal Colonization by Multidrug-Resistant Bacteria among Hematopoietic Stem-Cell Transplantation Recipients: A Bulgarian Single-Center Study.

19. Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter study

20. Innovative strategies against superbugs: Developing an AI-CDSS for precise Stenotrophomonas maltophilia treatment

21. Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study

22. Antibiotic Resistance and Virulence Factors in Clinical Isolates of Stenotrophomonas maltophilia from Hospitalized Patients in Tehran, Iran.

23. Microbial richness and air chemistry in aerosols above the PBL confirm 2,000-km long-distance transport of potential human pathogens.

24. Stenotrophomonas maltophilia uses a c-di-GMP module to sense the mammalian body temperature during infection.

25. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.

26. Selenium Bandages and Cotton Cloth That Kill Microorganisms in Wounds.

27. Anti-Stenotrophomonas maltophilia Mechanism of Rose Essential Oil: A Metabolomic Study.

28. Molecular detection of haemobacteria in Colombian wild birds.

29. Biodegradation of 17β‐estradiol by drug‐resistant Stenotrophomonas maltophilia MN08 and Pseudomonas aeruginosa KL10 isolated from the sediment sample.

30. Determination of in vitro synergy and antibiofilm activities of antimicrobials and essential oil components.

31. Microbiological Quality and Antibiotic Resistance of Relevant Bacteria from Horsemeat.

32. Germplasm Resource Mining of Fen-Flavor Baijiu Brewing Micro-Organisms and Screening of Important Functional Strains.

33. Acquired resistance of Stenotrophomonas maltophilia to antimicrobials induced by herbicide paraquat dichloride.

34. The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.

35. Evaluation of BACTECTM FX and BacT/AlertTM Automated Blood Culture Systems for Detection of Clinically Relevant Bacterial and Yeast Species.

36. Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.

37. Physiological and Biochemical Attributes of an Endophyte Stenotrophomonas maltophila, AVSW 1 Isolated from Chilli on PGP of Tomato.

38. Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia.

39. Plant-Based Substrates for the Production of Iron Bionanoparticles (Fe-BNPs) and Application in PCB Degradation with Bacterial Strains.

40. Characterization and genomic analysis of a lytic Stenotrophomonas maltophilia short-tailed phage A1432 revealed a new genus of the family Mesyanzhinovviridae.

41. Screening and identification of functional bacterial attachment genes in aerobic granular sludge.

42. Stenotrophomonas maltophilia‐associated odontogenic cerebral abscess in an immunocompetent patient: A case report.

43. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial Stenotrophomonas maltophilia Infections in Hospitalized Patients.

44. Stenotrophomonas Maltophilia Infection in Cancer Patients Undergoing Major Surgery in A Tertiary Cancer Centre.

45. Exploring Weissella confusa W1 and W2 Strains Isolated from Khao-Mahk as Probiotic Candidates: From Phenotypic Traits to Genomic Insights.

46. Stenotrophomonas maltophilia : The Landscape in Critically Ill Patients and Optimising Management Approaches.

47. Synthesis, biological evaluation, molecular docking analyses, and ADMET study of azo derivatives containing 1-naphthol against MβL-producing S. maltophilia

48. Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment.

50. Presence of intracellular bacterial communities in uroepithelial cells, a potential reservoir in symptomatic and non-symptomatic people

Catalog

Books, media, physical & digital resources